Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism
Data up to Jan 2025
Total Citations Per Year
Abstract
References (66)
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 • 4,142 citations
Vitamin D
1979 • 3,814 citations
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 • 3,652 citations
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study
2001 • 1,927 citations
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 • 1,778 citations
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 • 1,556 citations
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
2006 • 1,440 citations
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007 • 1,193 citations
Vitamin D Receptor As an Intestinal Bile Acid Sensor
2002 • 1,100 citations
Vitamin D
2005 • 1,077 citations
1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line.
2001 • 849 citations
1,25-Dihydroxyvitamin D3 Suppresses Renin Gene Transcription by Blocking the Activity of the Cyclic AMP Response Element in the Renin Gene Promoter
2007 • 480 citations
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
2005 • 371 citations
Diet-induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis via a Sterol Regulatory Element-binding Protein-1c-dependent Pathway
2005 • 365 citations
Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population
2009 • 365 citations
Role of Sterol Regulatory Element-binding Protein 1 in Regulation of Renal Lipid Metabolism and Glomerulosclerosis in Diabetes Mellitus
2002 • 327 citations
Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease
2008 • 324 citations
Renoprotective role of the vitamin D receptor in diabetic nephropathy
2007 • 296 citations
The RAAS in the pathogenesis and treatment of diabetic nephropathy
2010 • 296 citations
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
2008 • 285 citations
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
2006 • 283 citations
Regulation of Renal Lipid Metabolism, Lipid Accumulation, and Glomerulosclerosis in FVBdb/db Mice With Type 2 Diabetes
2005 • 281 citations
Regulation of Renal Fatty Acid and Cholesterol Metabolism, Inflammation, and Fibrosis in Akita and OVE26 Mice With Type 1 Diabetes
2006 • 277 citations
Suppression of renin–angiotensin gene expression in the kidney by paricalcitol
2008 • 262 citations
Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
2010 • 258 citations
Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
1998 • 248 citations
Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor–Mediated Sequestration of NF-κB Signaling
2008 • 247 citations
1,25-Dihydroxyvitamin D3decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat
2004 • 221 citations
Vitamin D Receptor Attenuates Renal Fibrosis by Suppressing the Renin-Angiotensin System
2010 • 220 citations
Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
2007 • 213 citations
Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D
2010 • 197 citations
Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats
2007 • 196 citations
Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial
2009 • 188 citations
Epidemiology of disease risks in relation to vitamin D insufficiency
2006 • 181 citations
1,25-Dihydroxyvitamin D3 targeting of NF-κB suppresses high glucose-induced MCP-1 expression in mesangial cells
2007 • 169 citations
The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria
2009 • 163 citations
Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients
2008 • 160 citations
A Vitamin D Analog Ameliorates Glomerular Injury on Rat Glomerulonephritis
2001 • 138 citations
The impact of vitamin D deficiency on diabetes and cardiovascular risk
2010 • 134 citations
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation
2008 • 132 citations
Renoprotective effects of vitamin D analogs
2009 • 129 citations
Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes
2010 • 127 citations
A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes
2010 • 124 citations
Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium
2008 • 120 citations
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats
2001 • 116 citations
Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease
2005 • 115 citations
Mechanism of Vitamin D Receptor Action
2006 • 108 citations
1,25-Dihydroxyvitamin D3suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-κB pathway
2009 • 102 citations
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression
2005 • 102 citations
Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial
2008 • 93 citations
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist
2009 • 91 citations
Calorie Restriction Modulates Renal Expression of Sterol Regulatory Element Binding Proteins, Lipid Accumulation, and Age-Related Renal Disease
2005 • 83 citations
22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats
2002 • 79 citations
Partial prevention of active Heymann nephritis by 1α, 25 dihydroxyvitamin D3
1993 • 75 citations
Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis
2007 • 68 citations
Potential role of active vitamin D in retarding the progression of chronic kidney disease
2006 • 68 citations
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease
2009 • 67 citations
Effects of increasing doses of 1α-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women
1994 • 64 citations
1α,25‐dihydroxyvitamin D3 triggered vitamin D receptor and farnesoid X receptor‐like effects in rat intestine and liver in vivo
2009 • 60 citations
Myocardial effects of VDR activators in renal failure
2010 • 56 citations
1,25-Dihydroxyvitamin D<sub>3</sub> Prevents Puromycin Aminonucleoside-Induced Apoptosis of Glomerular Podocytes by Activating the Phosphatidylinositol 3-Kinase/Akt-Signaling Pathway
2009 • 53 citations
Treatment with 1, 25-Dihydroxyvitamin D3 Preserves Glomerular Slit Diaphragm-Associated Protein Expression in Experimental Glomerulonephritis
2005 • 47 citations
Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction
2007 • 46 citations
Comparative Review of the Pharmacokinetics of Vitamin D Analogues
2002 • 41 citations
Expanding targets of vitamin D receptor activation: downregulation of several RAS components in the kidney
2008 • 36 citations
Nuclear hormone receptors in diabetic nephropathy
2010 • 34 citations